Your browser doesn't support javascript.
loading
Finding the junction between claudins and endometrial carcinoma.
Capoferri, Davide; Bignotti, Eliana; Ravaggi, Antonella; Mitola, Stefania; Romani, Chiara.
Affiliation
  • Capoferri D; Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
  • Bignotti E; Angelo Nocivelli Institute for Molecular Medicine, University of Brescia and ASST Spedali Civili di Brescia, Brescia 25123, Italy; Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia 25123, Italy.
  • Ravaggi A; Angelo Nocivelli Institute for Molecular Medicine, University of Brescia and ASST Spedali Civili di Brescia, Brescia 25123, Italy; Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia 25123, Italy.
  • Mitola S; Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
  • Romani C; Angelo Nocivelli Institute for Molecular Medicine, University of Brescia and ASST Spedali Civili di Brescia, Brescia 25123, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia 25123, Italy. Electronic address: chiara.romani@u
Biochim Biophys Acta Rev Cancer ; 1878(6): 189019, 2023 11.
Article de En | MEDLINE | ID: mdl-37951482
ABSTRACT
Endometrial carcinoma (EC) defines a heterogeneous group of neoplastic diseases originating from the transformation of endometrial cells that constitute the internal lining of the uterus. To date several molecular targets have been analysed to describe the natural course of the disease, claudins being among these. Claudins are the main components of tight junctions (TJs), and their main functions are ascribed to the compartmentalization of tissues and cell-cell communication by means of intracellular ions diffusion these features are typical of epithelial cells. Their overexpression, mis-localization or loss contribute to the malignancy of EC cells. This review collected all available data regarding the expression, regulation and claudin-related signaling pathways to provide a comprehensive view on the influence of claudin in EC progression. Further, the translational potential of claudin differential expression was explored, indicating that their role in personalized medicine could also contribute to EC therapy besides their employment for diagnosis and prognosis.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'endomètre / Claudines Limites: Female / Humans Langue: En Journal: Biochim Biophys Acta Rev Cancer Année: 2023 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'endomètre / Claudines Limites: Female / Humans Langue: En Journal: Biochim Biophys Acta Rev Cancer Année: 2023 Type de document: Article Pays d'affiliation: Italie